Matrine protects neuro-axon from CNS inflammation-induced injury

Experimental and Molecular Pathology

Volumn 98, Issue 1, 2015, Pages 124-130

  Kan, Quan Cheng ^a   Lv, Peng ^a   Zhang, Xiao Jian ^a   Xu, Yu Ming ^a   Zhang, Guang Xian ^b   Zhu, Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Axonal injury; EAE; Matrine; MS

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; MATRINE; METHYLPREDNISOLONE; MYELIN BASIC PROTEIN; ALKALOID; ASPARTIC PROTEINASE; BACE PROTEIN, RAT; BIOLOGICAL MARKER; MESSENGER RNA; PLANT EXTRACT; QUINOLIZINE DERIVATIVE; SECRETASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; DRUG EFFICACY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; NERVE CELL GROWTH; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CHEMISTRY; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FABACEAE; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; NERVE FIBER; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT;

RATTUS;

ALKALOIDS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; AXONS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FABACEAE; FEMALE; IMMUNOENZYME TECHNIQUES; INFLAMMATION; PLANT EXTRACTS; QUINOLIZINES; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84922623168     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.01.001     Document Type: Article

References (32)

1. Aleister J., Saunders, Tae-Wan K., Rudolph E., Tanzi BACE maps to chromosome 11 and a BACE homolog, BACE 2, reside in the obligate down syndrome region of chromosome 21. Science 1999, 286:5443.
2. Allaman I., Gavillet M., Bélanger M., Laroche T., Vierti D., Lashuel H.A., Maqistretti P.J. Amyloid-β aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J. Neurosci. 2010, 30(9):3326-3338.
3. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., Inestrosa N.C. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 2004, 297(1):186-196.
4. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001, 21:7724-7732.
5. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982, 1(5):549-553.
6. Bourquin C., Iglesias A., Berger T., Wekerle H., Linington C. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2000, 30:3663-3671.
7. Bu Z., Shi Y., Callaway D.J., Tycko R. Molecular alignment within beta-sheets in Abeta(14-23) fibrils: solid-state NMR experiments and theoretical predictions. Biophys. J. 2007, 92(2):594-602.
8. Chattopadhyay S., Myers R.R., Janes J., Shubayev V. Cytokine regulation of MMP 9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav. Immun. 2007, 21(5):561-568.
9. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 1997, 17(7):2295-2313.
10. D'Souza C.A., Moscarello M.A. Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope. Neurochem. Res. 2006, 31(8):1045-1054.
11. Ellwardt E., Zipp F. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS. Exp. Neurol. 2014, 10.1016/j.expneurol.2014.02.006.
12. Esch F.S., Keim P.S., Beattie, Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 1990, 248:1122-1124.
13. Haass C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 2004, 23:483-488.
14. Harvey A.R., Lovett S.J., Majda B.T., Yoon J.H., Wheeler L.P., Hodgetts S.I. Neurotrophic factors for spinal cord repair: which, where, how and when to apply, and for what period of time?. Brain Res. 2014, (pii: S0006-8993(14)01471-1, Epub ahead of print). 10.1016/j.brainres.2014.10.049.
15. Kan Q.C., Zhu L., Liu N., Zhang G.X. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity. Immunol. Res. 2013, 56(1):189-196.
16. Kim J.K., Mastronardi F.G., Wood D.D., Lubman D.M., Zand R., Moscarello M.A. Multiple sclerosis: an important role for post-translational modifications of myelinbasic protein in pathogenesis. Mol. Cell. Proteomics 2003, 2(7):453-462.
17. Kitiyanant N., Kitiyanant Y., Svendsen C.N., Thangnipon W. BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons. Neurochem. Res. 2012, 37(1):143-152.
18. Lassmann H. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal model. Exp. Neurol. 2010, 225(1):2-8.
19. Lindhagen-Persson M., Brännström K., Vestling M., Steinitz M., Olofsson A. Amyloid-β oligomer specificity mediated by the IgM isotype-implications for a specific protective mechanism exerted by endogenous auto-antibodies. PLoS One 2010, 5(11). 10.1371/journal.pone.0013928.
20. Makar T.K., Trisler D., Sura K.T., Sultana S., Patel N., Bever C.T. Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. J. Neurol. Sci. 2008, 270:70-76.
21. Melo M.E., Qian J., El-Amine M., Agarwal R.K., Soukhareva N., Kang Y., Scott D.W. Gene transfer of Ig-fusion proteins into B cells prevents and treat autoimmune diseases. J. Immunol. 2002, 168(9):4788-4795.
22. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008, 155:725-737.
23. Rommer P.S., Stüve O. Management of secondary progressive multiple sclerosis: prophy-lactic treatment-past, present, and future aspects. Curr. Treat. Options Neurol. 2013, 15(3):241-258.
24. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., Mccormack R., Wolfert R., Selekoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992, 359:325-327.
25. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M.A., Perry G., Tabaton M. Beta-site APP cleaving enzyme upregulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 2005, 92(3):628-636.
26. Terman A., Brunk U.T. Lipofuscin. Int. J. Biochem. Cell Biol. 2004, 36(8):1400-1404.
27. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking, processing and function. J. Biol. Chem. 2008, 283(44):29615-29619. 10.1074/jbc.R800019200.
28. Van der Stelt M., Mazzola C., Esposito G., Matias I., Petrosino S., De Filippis D., Micale V., Steardo L., Drago F., Iuvone T., Di Marzo V. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell. Mol. Life Sci. 2006, 63:1410-1424.
29. Wang Y., Lv T., Liu X., Fang M., Liang Y. Pathological findings of axonal injury in a rat model of experimental allergic encephalomyelitis. J. South. Med. Univ. 2012, 32(4):482-486.
30. Zeng Y., Zbao D., Xie C.W. Neurotrophins enhance CaMKII activity and rescue amyloid-13-induced deficits in hippocampal synaptic plasticity. J. Alzheimers Dis. 2010, 2(3):823-831.
31. Zhang S., Kan Q.C., Xu Y.M., Zhang G.X., Zhu L. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis. Mediat. Inflamm. 2013, 10.1155/2013/736085.
32. Zhao X., Kan Q., Zhu L., Zhang G.X. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis. Am. J. Chin. Med. 2011, 39(5):933-941.